TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3725002

Group type: EXPERIMENTAL
Intervention: Trazodone (100 mg) + Ethanol (0.5 ml/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Amitriptyline (50 mg) + Ethanol (0.5 ml/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ethanol (0.5 ml/kg) alone
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo + Ethanol (0.5 ml/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Trazodone (100 mg) alone
Number of subjects: 6

Group type: COMPARATOR
Intervention: Amitriptyline (50 mg) alone
Number of subjects: 6
Study: 31662331

Group type: EXPERIMENTAL
Intervention: 24 weeks of lapatinib and trastuzumab
Number of subjects: 97

Group type: COMPARATOR
Intervention: 12 weeks of lapatinib and trastuzumab
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 24 weeks of lapatinib and trastuzumab in ER-positive subgroup
Number of subjects: 97

Group type: COMPARATOR
Intervention: 12 weeks of lapatinib and trastuzumab in ER-positive subgroup
Number of subjects: 97
Study: 29503102

Group type: EXPERIMENTAL
Intervention: Training session using voices different from those in the experimental session but of the same voice category
Number of subjects: 0

Group type: COMPARATOR
Intervention: No training
Number of subjects: 0
Study: 27906936

Group type: EXPERIMENTAL
Intervention: Lidocaine-nalbuphine (LN) group
Number of subjects: 106

Group type: COMPARATOR
Intervention: Lidocaine (L) group
Number of subjects: 106
Study: 25518506

Group type: EXPERIMENTAL
Intervention: Dinitrosyl iron complex (1.5 or 3 mg/kg)
Number of subjects: 30
Study: 22507264

Group type: EXPERIMENTAL
Intervention: Yoga therapy (suryanamaskara, asanas, pranayama, and meditation) for 1 hour per day for 12 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional physical exercises
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Yoga therapy
Number of subjects: 90
Study: 20442215

Group type: EXPERIMENTAL
Intervention: Baseline chest radiograph (CXR) followed by three annual single-view CXRs.
Number of subjects: 77464
Study: 18544464

Group type: EXPERIMENTAL
Intervention: Disease management program for smoking cessation combining pharmacotherapy, telephone counseling, and physician feedback, repeated intervention over two years.
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Disease management program for smoking cessation
Number of subjects: 750
Study: 16402744

Group type: EXPERIMENTAL
Intervention: Reality monitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: External source monitoring
Number of subjects: 0
Study: 12504838

Group type: EXPERIMENTAL
Intervention: BQ-123 alone
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: BQ-123 combined with BQ-788
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: BQ-123 alone and combined with BQ-788
Number of subjects: 13
Study: 10397414

Group type: EXPERIMENTAL
Intervention: Schizophrenic patients
Number of subjects: 39

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Schizophrenic patients and family history positive parents
Number of subjects: 39

Group type: COMPARATOR
Intervention: Family history negative parents and normal subjects
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Duration of illness, neuroleptic medication, and negative symptoms
Number of subjects: 39
Study: 10180853

Group type: EXPERIMENTAL
Intervention: Counselling intervention
Number of subjects: 1
Study: 1812479

Group type: EXPERIMENTAL
Intervention: Euphylong
Number of subjects: 17

Group type: COMPARATOR
Intervention: Reference drug
Number of subjects: 17
Study: 6980622

Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: TMP-SMX
Number of subjects: 263
Study: 30531478

Group type: COMPARATOR
Intervention: Cebranopadol 200 μg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Cebranopadol 400 μg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cebranopadol 800 μg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Hydromorphone 8 mg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Hydromorphone 16 mg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 28728869

Group type: EXPERIMENTAL
Intervention: Running subcuticular sutures (RSS)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Simple interrupted sutures (SIS)
Number of subjects: 142
Study: 27026365

Group type: EXPERIMENTAL
Intervention: High-dose hemodialysis (Kt/Vurea of 1.71)
Number of subjects: 1281

Group type: EXPERIMENTAL
Intervention: High-dose hemodialysis
Number of subjects: 1281

Group type: COMPARATOR
Intervention: Standard treatment (Kt/Vurea of 1.32)
Number of subjects: 1281
Study: 24759796

Group type: EXPERIMENTAL
Intervention: Prasugrel (20/3.75 mg)
Number of subjects: 1363

Group type: COMPARATOR
Intervention: Clopidogrel (300/75 mg)
Number of subjects: 1363
Study: 21986689

Group type: EXPERIMENTAL
Intervention: AT before ST
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: AT between 2 blocks of ST
Number of subjects: 8

Group type: COMPARATOR
Intervention: AT after ST
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All sequences
Number of subjects: 8
Study: 19531038

Group type: EXPERIMENTAL
Intervention: Quick change (QC) method
Number of subjects: 30

Group type: COMPARATOR
Intervention: Double pumping (DP) method
Number of subjects: 30
Study: 17688173

Group type: COMPARATOR
Intervention: Ciprofloxacin with water
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin with Five Alive fruit juice
Number of subjects: 11
Study: 15356662

Group type: EXPERIMENTAL
Intervention: Surgical treatment (average weight loss of 28 kg)
Number of subjects: 3756

Group type: EXPERIMENTAL
Intervention: Conventional treatment (weight stable)
Number of subjects: 3756

Group type: COMPARATOR
Intervention: Reference group (normal-weight subjects)
Number of subjects: 3756
Study: 11145766

Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Midazolam plus Nitrous oxide
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 204
Study: 9840527

Group type: EXPERIMENTAL
Intervention: DNA flow cytometry (DNA‐FCM) analysis
Number of subjects: 110
Study: 8302340

Group type: EXPERIMENTAL
Intervention: Riluzole (100 mg per day)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 2735022

Group type: EXPERIMENTAL
Intervention: Kinetic treatment table (KTT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional bed
Number of subjects: 30
Study: 1093638

Group type: EXPERIMENTAL
Intervention: Ampicillin (two oral doses of 1 g. 5 hours apart)
Number of subjects: 1124

Group type: COMPARATOR
Intervention: Doxycycline (0.3 g. single oral dose)
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 1124

Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 1124
Study: 30987813

Group type: EXPERIMENTAL
Intervention: Sun exposure (daily ≥20–30 min around noon)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Oral vitamin D3 (500 IU/d)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 30646944

Group type: EXPERIMENTAL
Intervention: Intervention 1: Clinician-guided self-management program (iFightDepression®)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Intervention 2: Clinician-guided group chat intervention
Number of subjects: 363

Group type: COMPARATOR
Intervention: Control intervention: Psycho-educational website on depressive symptoms
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 363
Study: 28099478

Group type: EXPERIMENTAL
Intervention: Interactive information delivery using an online trivia-style gamification platform
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive information delivery via Amazon Mechanical Turk
Number of subjects: 0
Study: 26054203

Group type: EXPERIMENTAL
Intervention: Acupuncture plus bloodletting
Number of subjects: 120

Group type: COMPARATOR
Intervention: Simple acupuncture therapy
Number of subjects: 120
Study: 23775222

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention
Number of subjects: 37
Study: 21811202

Group type: EXPERIMENTAL
Intervention: Triage team present (physician, nurse, and nurse assistant)
Number of subjects: 1726

Group type: EXPERIMENTAL
Intervention: Triage team present
Number of subjects: 1726

Group type: COMPARATOR
Intervention: No triage team present
Number of subjects: 1726
Study: 18695308

Group type: EXPERIMENTAL
Intervention: Dalteparin (low molecular-weight heparin)
Number of subjects: 99

Group type: COMPARATOR
Intervention: No drug (control)
Number of subjects: 99
Study: 16950471

Group type: EXPERIMENTAL
Intervention: Phenylephrine challenge during intra-operative assessment
Number of subjects: 57

Group type: COMPARATOR
Intervention: Intra-operative assessment without phenylephrine
Number of subjects: 57
Study: 12867583

Group type: COMPARATOR
Intervention: Diffuse systemic sclerosis (dSSc) patients
Number of subjects: 234

Group type: COMPARATOR
Intervention: Haplotype distribution in dSSc patients
Number of subjects: 234
Study: 10863252

Group type: EXPERIMENTAL
Intervention: Cervical rotary manipulation on the ipsilateral side of the lateral flexion fixation(s) (Group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Supine lateral break manipulation on the contralateral side of the lateral flexion fixation(s) (Group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both treatments (Group A and Group B)
Number of subjects: 30
Study: 9202555

Group type: EXPERIMENTAL
Intervention: Pelvic muscle exercise
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Urethral milking
Number of subjects: 49

Group type: COMPARATOR
Intervention: Counselling
Number of subjects: 49
Study: 1440485

Group type: COMPARATOR
Intervention: Routine diagnostic approach
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Use of a lung segment reference chart
Number of subjects: 220
Study: 2429844

Group type: EXPERIMENTAL
Intervention: Propafenone 300 mg single dose
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Propafenone 150 mg t.i.d. multiple doses
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Propafenone 150 mg and 300 mg single doses
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Propafenone metabolites
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Therapeutic range of propafenone (0.5-2.0 micrograms/ml)
Number of subjects: 11
Study: 31162082

Group type: EXPERIMENTAL
Intervention: Laparoscopic peritoneal lavage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sigmoidectomy
Number of subjects: 0
Study: 30253403

Group type: EXPERIMENTAL
Intervention: CinnaPoietin® (epoetin beta, CinnaGen)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Eprex® (epoetin alfa, Janssen Cilag)
Number of subjects: 156
Study: 27147591

Group type: EXPERIMENTAL
Intervention: CBT plus modafinil (400 mg/day)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Only CBT
Number of subjects: 65
Study: 25011693

Group type: EXPERIMENTAL
Intervention: Irbesartan 300mg daily
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 22542724

Group type: EXPERIMENTAL
Intervention: Metreleptin (0.02 mg/kg/d for two months; 0.04 mg/kg/d for a further two months)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 19898246

Group type: EXPERIMENTAL
Intervention: ZDV/3TC/LPV/r
Number of subjects: 0

Group type: COMPARATOR
Intervention: NVP/LPV/r
Number of subjects: 0
Study: 17629471

Group type: EXPERIMENTAL
Intervention: Trained group (VT) using MDI
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Trained group (VT) using SDSK
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Trained group (VT) using STBH
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Trained group (VT) using SHAND
Number of subjects: 163

Group type: COMPARATOR
Intervention: Non-trained group (NT)
Number of subjects: 163
Study: 15668620

Group type: EXPERIMENTAL
Intervention: Booster counseling
Number of subjects: 1653

Group type: COMPARATOR
Intervention: No booster counseling
Number of subjects: 1653
Study: 14561567

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10928294

Group type: EXPERIMENTAL
Intervention: Cyclosporin (CyA)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Azathioprine (Aza)
Number of subjects: 46
Study: 8695711

Group type: EXPERIMENTAL
Intervention: TPN with exclusive use catheter (Group I)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: TPN with a catheter through which antibiotic medication is administered in 'Y' (Group II)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: TPN with a catheter through which non-antibiotic medication is administered in 'Y' (Group III)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison of infection and number of manipulations
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison of infection and number of days of treatment with TPN
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison of number of manipulations between groups II and III
Number of subjects: 70
Study: 1505148

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (100 mg/kg)
Number of subjects: 11
Study: 6702463

Group type: EXPERIMENTAL
Intervention: Activated charcoal (50 g) after aspirin (1000 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Activated charcoal (50 g) after quinidine sulfate (200 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ethanol (10%)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Concomitant ingestion of alcohol (50 g) with drugs
Number of subjects: 6
Study: 31096648

Group type: EXPERIMENTAL
Intervention: Sunflower seed extract (500 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isocaloric placebo
Number of subjects: 50
Study: 29334275

Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian drilling (LOD)
Number of subjects: 250

Group type: COMPARATOR
Intervention: GnRH antagonist (Cetrotide 0.25 mg) combined with cabergoline (0.5 mg a day for 8 days)
Number of subjects: 250
Study: 26583952

Group type: EXPERIMENTAL
Intervention: Confocal laser endomicroscopy (CLE)
Number of subjects: 50
Study: 24985574

Group type: EXPERIMENTAL
Intervention: 0.1% pranoprofen (PRA) plus 0.1% sodium hyaluronate (SH)
Number of subjects: 115

Group type: COMPARATOR
Intervention: 0.1% sodium hyaluronate (SH) only
Number of subjects: 115
Study: 22840583

Group type: EXPERIMENTAL
Intervention: Forest environment (two-night trip to a broad-leaved evergreen forest)
Number of subjects: 20

Group type: COMPARATOR
Intervention: City area (control group)
Number of subjects: 20
Study: 20400723

Group type: EXPERIMENTAL
Intervention: Removable dental prostheses (RDP) for molar replacement
Number of subjects: 215

Group type: COMPARATOR
Intervention: No replacement (SDA)
Number of subjects: 215
Study: 17656221

Group type: EXPERIMENTAL
Intervention: zoledronic acid
Number of subjects: 120

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 120
Study: 16302838

Group type: EXPERIMENTAL
Intervention: Breast-feeding
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Pacifier use while held by mothers
Number of subjects: 96

Group type: COMPARATOR
Intervention: Pacifier use while held by nonmothers
Number of subjects: 96
Study: 11973385

Group type: EXPERIMENTAL
Intervention: Excimer laser trephination
Number of subjects: 170

Group type: COMPARATOR
Intervention: Motor trephination (Control)
Number of subjects: 170
Study: 9862245

Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b (IFN) 3 million IU thrice weekly s.c. alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ribavirin 600 mg twice daily p.o. alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of IFN and ribavirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon alpha‐2b (IFN) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ribavirin alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy (IFN + ribavirin)
Number of subjects: 0
Study: 8536590

Group type: EXPERIMENTAL
Intervention: Prone position (Hmax/Mmax = 73.6%)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standing position (Hmax/Mmax = 32.4%)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Old subjects who depressed the reflex (O-D, n = 6)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Old subjects who did not depress the reflex (O-ND, n = 9)
Number of subjects: 25
Study: 2146325

Group type: EXPERIMENTAL
Intervention: 13-cis retinoic acid (1 mg/kg/day for 4 months)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no 13-cis RA)
Number of subjects: 26
Study: 524332

Group type: EXPERIMENTAL
Intervention: Björk-Shiley (B-S) valve
Number of subjects: 48

Group type: COMPARATOR
Intervention: Lillehei-Kaster (L-K) valve
Number of subjects: 48
Study: 31830885

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 25
Study: 31509971

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed guar gum (PHGG) for 3 months
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed guar gum (PHGG)
Number of subjects: 44
Study: 29727544

Group type: EXPERIMENTAL
Intervention: Fuyang Huayu Prescription (Traditional Chinese Medicine)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Endocrine therapy and chemotherapy (Control)
Number of subjects: 54
Study: 26282418

Group type: EXPERIMENTAL
Intervention: Ombitasvir plus paritaprevir/ritonavir (with or without ribavirin)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 132
Study: 23334341

Group type: EXPERIMENTAL
Intervention: AVAXIM 80U Pediatric
Number of subjects: 720

Group type: COMPARATOR
Intervention: HAVRIX 720
Number of subjects: 720
Study: 20625336

Group type: EXPERIMENTAL
Intervention: Instructor-only training
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Automated feedback only
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Instructor training combined with automated feedback
Number of subjects: 69
Study: 19950808

Group type: EXPERIMENTAL
Intervention: Conventional technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: Piggyback technique
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 30
Study: 16407806

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural analgesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no analgesia)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidural analgesia and combined spinal-epidural analgesia
Number of subjects: 0
Study: 15013244

Group type: EXPERIMENTAL
Intervention: Clonazepam
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 206
Study: 11686809

Group type: EXPERIMENTAL
Intervention: Oscillating rotating electric toothbrush with faster head movement
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oscillating rotating electric toothbrush with slower head movement
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oscillating rotating reciprocating model
Number of subjects: 24
Study: 9598257

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 30
Study: 7945822

Group type: EXPERIMENTAL
Intervention: Honey-impregnated gauze
Number of subjects: 64

Group type: COMPARATOR
Intervention: Amniotic membrane
Number of subjects: 64
Study: 3556145

Group type: EXPERIMENTAL
Intervention: Tryptophan 250 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Tryptophan 500 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Tryptophan with sodium salicylate
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31618812

Group type: EXPERIMENTAL
Intervention: Saffron (20 mg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 28181975

Group type: EXPERIMENTAL
Intervention: Auricular acupressure therapy (2 weeks, 2 times per week, using auricular acupressure needle on skin paper tape)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo control (skin paper tape without auricular acupressure needle)
Number of subjects: 67
Study: 25956572

Group type: EXPERIMENTAL
Intervention: 0.03% tacrolimus eye drop
Number of subjects: 24

Group type: COMPARATOR
Intervention: Vehicle (almond oil)
Number of subjects: 24
Study: 23725688

Group type: EXPERIMENTAL
Intervention: Sevoflurane 1%-3%
Number of subjects: 32

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 32
Study: 21570617

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 60
Study: 19231397

Group type: EXPERIMENTAL
Intervention: Lidocaine (standard antiarrhythmic dose)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 17163356

Group type: EXPERIMENTAL
Intervention: ACE inhibitors (ACEIs)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 60
Study: 15129937

Group type: EXPERIMENTAL
Intervention: Cochlear implantation with pre-implantation control of OM using a structured protocol and ventilating tube insertion if necessary.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cochlear implantation in OM-prone children with a structured protocol.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cochlear implantation in OM-prone children.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cochlear implantation in children.
Number of subjects: 60
Study: 11265021

Group type: EXPERIMENTAL
Intervention: Aged stored RBCs (21 or 42 days)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Washed 42-day-old RBCs
Number of subjects: 1

Group type: COMPARATOR
Intervention: Leukoreduced RBCs
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Stored packed RBCs
Number of subjects: 1